Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00223-025-01440-3
PubMed Identifier: 41206390
Publication URI: http://europepmc.org/abstract/MED/41206390
Type: Journal Article/Review
Volume: 116
Parent Publication: Calcified tissue international
Issue: 1
ISSN: 0171-967X